Javascript must be enabled to continue!
Dissection of functional domains in Bcl-2α by site-directed mutagenesis
View through CrossRef
Bcl-2α is a mitochondrial or perinuclear-associated oncoprotein that prolongs the life span of a variety of cell types by interfering with programmed cell death. How Bcl-2 confers cell survival is unknown, although antioxidant and antiprotease functions have been proposed. In addition, protein structures of Bcl-2 that are crucial for its survival activity are still ill-defined. Bcl-2 can occur as Bcl-2α or Bcl-2β, two alternatively spliced forms which solely differ in their carboxyl termini. The finding that Bcl-2α is active and membrane bound, but Bcl-2β is inactive and cytosolic, indicates that the carboxyl terminus contributes to the survival activity of Bcl-2. This region contains two subdomains, a domain X with unknown function and a hydrophobic stretch reported to mediate membrane assocation of Bcl-2α. Recently Bcl-2-related proteins have been identified. These include Bax that heterodimerizes with Bcl-2 and, when overxpressed, counteracts Bcl-2. Bax contains two highly conserved regions of sequence homology with Bcl-2, referred to as Bcl-2 homology 1 and 2 (BH1 and BH2) domains. Site-directed mutagenesis studies have revealed that both domains are not only novel dimerization motifs for the interaction of Bax with Bcl-2 but also crucial for the survival activity of Bcl-2. Interestingly, the C-terminal end of BH2 encompasses the Bcl-2α/β splice site, as well as part of domain X in Bcl-2α. To better define the role of domain X and the hydrophobic C-terminal stretch of Bcl-2α for its survival activity, we created various deletion and truncation mutations in these regions by site-directed mutagenesis. We show here that membrane attachment and therefore the hydrophobic stretch is not required for the survival activity of Bcl-2, but part of domain X appears to be indispensable.Key words: apoptosis, Bcl-2, mutagenesis, cell survival, functional domains.
Canadian Science Publishing
Title: Dissection of functional domains in Bcl-2α by site-directed mutagenesis
Description:
Bcl-2α is a mitochondrial or perinuclear-associated oncoprotein that prolongs the life span of a variety of cell types by interfering with programmed cell death.
How Bcl-2 confers cell survival is unknown, although antioxidant and antiprotease functions have been proposed.
In addition, protein structures of Bcl-2 that are crucial for its survival activity are still ill-defined.
Bcl-2 can occur as Bcl-2α or Bcl-2β, two alternatively spliced forms which solely differ in their carboxyl termini.
The finding that Bcl-2α is active and membrane bound, but Bcl-2β is inactive and cytosolic, indicates that the carboxyl terminus contributes to the survival activity of Bcl-2.
This region contains two subdomains, a domain X with unknown function and a hydrophobic stretch reported to mediate membrane assocation of Bcl-2α.
Recently Bcl-2-related proteins have been identified.
These include Bax that heterodimerizes with Bcl-2 and, when overxpressed, counteracts Bcl-2.
Bax contains two highly conserved regions of sequence homology with Bcl-2, referred to as Bcl-2 homology 1 and 2 (BH1 and BH2) domains.
Site-directed mutagenesis studies have revealed that both domains are not only novel dimerization motifs for the interaction of Bax with Bcl-2 but also crucial for the survival activity of Bcl-2.
Interestingly, the C-terminal end of BH2 encompasses the Bcl-2α/β splice site, as well as part of domain X in Bcl-2α.
To better define the role of domain X and the hydrophobic C-terminal stretch of Bcl-2α for its survival activity, we created various deletion and truncation mutations in these regions by site-directed mutagenesis.
We show here that membrane attachment and therefore the hydrophobic stretch is not required for the survival activity of Bcl-2, but part of domain X appears to be indispensable.
Key words: apoptosis, Bcl-2, mutagenesis, cell survival, functional domains.
Related Results
Abstract 1583: Bcl-6 as a potential therapeutic target for bladder cancer
Abstract 1583: Bcl-6 as a potential therapeutic target for bladder cancer
Abstract
Introduction and Objectives: B-cell lymphoma 6 (Bcl-6) is known to be a nuclear protein and a master transcription factor for regulation of T follicular hel...
Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of bcl-2
Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of bcl-2
Apoptosis plays a critical role during development and in the maintenance of the vascular system. B-cell leukemia lymphoma 2 (bcl-2) protects endothelial cells (EC) from apoptosis ...
Characterization of the anti-apoptotic mechanism of Bcl-B
Characterization of the anti-apoptotic mechanism of Bcl-B
Bcl-B protein is an anti-apoptotic member of the Bcl-2 family protein that contains all the four BH (Bcl-2 homology) domains (BH1, BH2, BH3 and BH4) and a predicted C-terminal tran...
Abstract 1650: Bone marrow microenvironment control of BCL-6 in acute lymphocytic leukemia .
Abstract 1650: Bone marrow microenvironment control of BCL-6 in acute lymphocytic leukemia .
Abstract
BCL-6 is a proto-oncogene that encodes for a BTB/POZ-zinc-finger transcriptional repressor, classically described in the regulation of germinal center (GC) ...
Specific Primer for Human Bcl-2-Protein Expression Analysis
Specific Primer for Human Bcl-2-Protein Expression Analysis
Bcl-2 protein (B-cell lymphoma 2) is one of the proteins in the Bcl-2 protein family that are anti apoptotic and encoded by the BCL-2 gene. This protein controls the permeability o...
Abstract 7: PARP and Bcl-2 co-inhibition in small cell lung cancer (SCLC)
Abstract 7: PARP and Bcl-2 co-inhibition in small cell lung cancer (SCLC)
Abstract
Background: Small cell lung cancer (SCLC) accounts for 10-15% of all lung cancers. SCLC is initially responsive to chemotherapy, but quickly relapses. With ...
Ultra‐thin benzalkonium chloride‐doped poly(lactic acid) electrospun mat
Ultra‐thin benzalkonium chloride‐doped poly(lactic acid) electrospun mat
AbstractIn this study, poly(lactic acid), poly(ethylene glycol), and benzalkonium chloride with different concentrations (3, 5, 7, and 9%wt.) (PLA/PEG/BCL) composite electrospun ma...
Histone Deacetylase Inhibitor Downregulation of bcl-xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma
Histone Deacetylase Inhibitor Downregulation of bcl-xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma
Abstract
It has been shown that mesothelioma expresses the antiapoptotic protein BCL-XL, but not BCL-2, rendering bcl-xl gene expression a potential therapeutic t...

